For patients undergoing MAD, carnitine levels are initially evaluated at baseline (prior to starting ketogenic therapy)
Side effects: Both can cause stomach issues (like nausea), but semaglutide may be slightly worse when increasing doses
Nanuka Tsibadze and colleagues at Jefferson Einstein Philadelphia conducted a nationwide retrospective analysis of 4,104 PsA patients on GLP-1s versus 86,432 PsA patients not on GLP-1s. The results: Mortality: 1.4% in the GLP-1 group vs
A complex distillation process involving fermentation, centrifugation, cell extraction, filtration, and crystallisation is used to achieve purity
Before participating in a clinical trial, you need to call or email the USADA Drug Reference Line to determine if a Therapeutic Use Exemption is required